Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-25-046838
Filing Date
2025-05-09
Accepted
2025-05-09 17:12:42
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 tm2514403d1_424b5.htm 424B5 289902
2 GRAPHIC image_001.jpg GRAPHIC 3273
  Complete submission text file 0001104659-25-046838.txt   295530
Mailing Address 1 BRIDGE PLAZA, SUITE 275 FORT LEE NJ 07024
Business Address 1 BRIDGE PLAZA, SUITE 275 FORT LEE NJ 07024 360-837-7232
Nuvectis Pharma, Inc. (Filer) CIK: 0001875558 (see all company filings)

EIN.: 862405608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-270657 | Film No.: 25931591
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)